Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6418
    -0.0007 (-0.11%)
     
  • OIL

    83.80
    +1.07 (+1.29%)
     
  • GOLD

    2,401.20
    +3.20 (+0.13%)
     
  • Bitcoin AUD

    100,363.02
    +5,353.66 (+5.63%)
     
  • CMC Crypto 200

    1,329.26
    +16.64 (+1.27%)
     
  • AUD/EUR

    0.6025
    -0.0005 (-0.09%)
     
  • AUD/NZD

    1.0889
    +0.0014 (+0.13%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,841.80
    -35.25 (-0.45%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,660.53
    -176.87 (-0.99%)
     
  • Hang Seng

    16,235.93
    -149.94 (-0.92%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

What Next for Imperva?

What Next for Imperva?

Imperva (IMPV) now looks to be firmly on track to be acquired by Thoma Bravo after its go-shop window closed. On October 10, Imperva announced an agreement that involved investment company Thoma Bravo acquiring it for $55.75 per share in cash or $2.1 billion in total. The agreement provided a 45-day window for Imperva to consider alternative acquisition proposals that may come its way.